查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941057

電子處方箋市場－全球產業規模、佔有率、趨勢、機會和預測：按組件、交付方式、最終用戶、地區和競爭格局分析（2021-2031年）

E-Prescription Market - Global Industry Size, Share, Trends, Opportunity and Forecast, Segmented By Component, By Mode Of Delivery, By End-User Segment Analysis, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球電子處方箋市場預計將從 2025 年的 41.4 億美元成長到 2031 年的 123.7 億美元，複合年成長率達到 20.01%。

該市場的特點是醫療機構直接向處方箋數位化創建和傳輸處方。此流程旨在取代手寫醫囑，最大限度地減少解讀錯誤，並最佳化藥品配發流程。推動此成長的關鍵因素包括：為提高病患安全，必須減少不利事件；以及政府法規強制要求採用數位化技術，以提高醫療互通性。這些促進因素並非暫時的市場趨勢，而是代表著向合規性和營運效率的根本結構轉變。

市場概覽
預測期 2027-2031
市場規模：2025年 41.4億美元
市場規模：2031年 123.7億美元
複合年成長率：2026-2031年 20.01%
成長最快的細分市場 網路/雲端為基礎的解決方案
最大的市場 北美洲

然而，市場擴張仍面臨許多障礙。確保資料安全穩健的複雜性以及實施所需的高昂基礎設施成本是關鍵挑戰，尤其是在發展中地區。患者隱私問題以及不聯網系統之間的相容性不足也是重要的障礙。儘管存在這些挑戰，但採用率指標表明，人們對這些平台的依賴程度很高。 Surescripts報告稱，到2024年，其網路將處理26億份電子處方箋，凸顯了其龐大的使用規模。這項數據表明，儘管克服了安全全球部署的技術複雜性，該行業仍保持持續成長。

市場促進因素

政府的利好政策以及相關法規和政策的實施是全球電子處方箋市場發展的關鍵促進因素。世界各國政府正在推行數位醫療標準，以確保互通性，從而有效地以安全的電子系統取代紙本工作流程。這些法規不僅強制執行，還建立了廣泛的醫療資料交換基礎設施。例如，英國國家醫療服務體系（NHS）商業服務部門報告稱，截至2025年10月，透過電子處方箋服務（EPS）配發的藥品數量達到11.3億份，佔英格蘭所有處方箋的97%。同樣，Surescripts於2025年3月發布的《2024年影響報告》指出，該網路在2024年交換了272億筆醫療資訊交易，充分展現了此類監管合作的巨大規模。

第二個關鍵促進因素是迫切需要最大限度地減少用藥錯誤並提高病人安全。手寫處方箋潦草且容易被誤解，而數位化處方則提供自動化的臨床決策支持，例如藥物交互作用檢查和劑量提醒。這些功能可直接減少可預防的不利事件，而藥物不良事件仍是導致患者傷害的主要原因之一。近期臨床研究也支持這些安全優勢。 Taylor & Francis 於 2024 年 12 月發表的一項研究發現，在一家三級醫療機構實施改進的電子處方箋後，整體處方箋錯誤率從 1.43% 降至 0.51%。這種保護患者健康的能力已得到證實，確保安全仍然是市場持續投資的關鍵促進因素。

市場挑戰

確保資料安全穩健的複雜性以及實施過程中高昂的基礎設施成本，對全球電子處方箋市場的擴張構成了重大障礙。這些財務和技術難題為醫療服務提供者設定了很高的進入門檻，尤其對小規模診所和醫療機構，特別是發展中地區的機構，造成了不成比例的影響。建構安全、可互通的網路所需的大量投資迫使各機構將大量資源從臨床服務轉移到網路安全基礎設施。因此，高昂的擁有成本減緩了電子處方的普及，而持續存在的網路攻擊威脅則削弱了相關人員從紙本工作流程全面過渡到數位系統所需的信任。

近期產業數據顯示，醫療資訊系統存在許多漏洞，凸顯了當前嚴峻的安全情勢。美國醫院協會 (AHA) 發布的《2025 年報告》預測，到 2024 年底，將有 2.59 億美國人的受保護健康資訊遭到駭客攻擊。這令人震驚的數據表明，電子處方箋平台必須應對的安全風險規模之大。應對如此廣泛的漏洞需求推高了實施成本，增加了無縫全球解決方案推廣的難度，並限制了市場的快速擴張能力。

市場趨勢

電子預先核准(ePA) 工作流程自動化正在改變市場格局，它以即時演算法核准取代繁瑣的人工流程。這一趨勢直接消除了延誤患者獲得藥物的行政瓶頸，並超越了簡單的數位化，實現了完全「非接觸式」核准。透過將支付方標準直接整合到處方工作流程中，醫療服務提供者可以即時獲得批准結果，並顯著減少電話和傳真溝通所花費的時間。 Surescripts 在 2025 年 3 月發布的《2024 年影響報告》中重點強調了這一效率提升，指出非接觸式預先核准功能將平均核准時間從一個多小時縮短至僅 34 秒，充分展現了先進自動化技術所能帶來的顯著效率提升。

同時，人工智慧 (AI) 在臨床決策支援中的應用正在提高處方箋的準確性和速度。人工智慧演算法正被擴大用於自動化處理複雜任務，例如解讀非結構化臨床數據以及將說明指令轉換為結構化程式碼，從而最大限度地減少人為錯誤和人工輸入的疲勞。這項技術進步使系統能夠智慧地預測並自動填充處方箋詳情，從而提高藥房的資料完整性。正如 Hackensack Meridian Health 在 2025 年 7 月發布的新聞稿中所述，該公司與 DrFirst 合作，部署臨床級人工智慧成功地自動映射了 30 萬份藥品樣本中 86% 的患者適應症 (SIG)，這充分展現了人工智慧在簡化大量處方操作方面的能力。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球電子處方箋市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按組件（解決方案{獨立解決方案和整合解決方案}和服務）
    • 按交付類型（本地部署與基於 Web/雲端的解決方案）
    • 依最終用戶細分市場（醫院、藥局、診所）進行分析
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美電子處方箋市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲電子處方箋市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區電子處方箋市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲電子處方箋市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美電子處方箋市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球電子處方箋市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Cerner Corporation
  • Allscripts Healthcare Solutions, Inc.
  • Epic Systems Corporation
  • McKesson Corporation
  • eClinicalWorks LLC
  • GE Healthcare
  • NextGen Healthcare, Inc.
  • DrFirst, Inc.
  • Greenway Health, LLC
  • Practice Fusion, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7866

The Global E-Prescription Market is projected to expand from USD 4.14 Billion in 2025 to USD 12.37 Billion by 2031, achieving a Compound Annual Growth Rate (CAGR) of 20.01%. This market is characterized by the digital creation and transmission of medical prescriptions from healthcare providers directly to pharmacies, a process designed to supersede handwritten orders to minimize interpretation errors and optimize medication dispensing workflows. The primary catalysts propelling this growth include the imperative need to lower adverse drug events for better patient safety and government mandates enforcing digital adoption to improve healthcare interoperability. These drivers represent fundamental structural changes toward regulatory compliance and operational efficiency rather than fleeting market trends.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.14 Billion
Market Size 2031USD 12.37 Billion
CAGR 2026-203120.01%
Fastest Growing SegmentWeb/Cloud-based solutions
Largest MarketNorth America

However, market expansion faces significant obstacles, primarily the intricacy of guaranteeing robust data security and the substantial infrastructure costs required for implementation, especially in developing areas. Issues regarding patient privacy and the compatibility of disconnected systems persist as major barriers. Despite these challenges, adoption metrics demonstrate a heavy reliance on these platforms. As reported by Surescripts, 2.6 billion electronic prescriptions were processed through their network in 2024, highlighting the immense scale of utilization. This volume underscores the sector's continued momentum even as it navigates the technical complexities associated with secure global deployment.

Market Driver

The enforcement of favorable government mandates and regulatory policies acts as the primary catalyst for the global e-prescription market. Governments globally are implementing digital health standards to ensure interoperability, effectively replacing paper-based workflows with secure electronic systems. These regulations not only necessitate adoption but also establish a vast infrastructure for health data exchange. For instance, the NHS Business Services Authority reported in October 2025 that 1.13 billion items were dispensed via the Electronic Prescription Service (EPS), accounting for 97% of all prescription items in England. Similarly, Surescripts' '2024 Annual Impact Report' from March 2025 noted that their network exchanged 27.2 billion health intelligence transactions in 2024, demonstrating the massive scale facilitated by these regulatory connections.

A second critical driver is the urgent need to minimize medication errors and enhance patient safety. While manual prescribing methods are susceptible to illegibility and misinterpretation, digital alternatives provide automated clinical decision support, such as drug-drug interaction verifications and dosing alerts. These capabilities directly mitigate preventable adverse drug events, which remain a major source of patient harm. Recent clinical research validates these safety benefits; a study published by Taylor & Francis in December 2024 revealed that implementing e-prescribing modifications in a tertiary hospital lowered the overall prescribing error rate from 1.43% to 0.51%. This demonstrated capacity to safeguard patient health ensures that safety remains a primary incentive for continued market investment.

Market Challenge

The complexity of ensuring robust data security and the high infrastructure costs associated with implementation act as significant barriers to the expansion of the Global E-Prescription Market. These financial and technical hurdles create a steep barrier to entry for healthcare providers, disproportionately affecting smaller practices and institutions in developing regions. The substantial investment required to establish secure, interoperable networks forces organizations to divert critical resources from clinical services to cybersecurity infrastructure. Consequently, the high cost of ownership slows the adoption rate, while the persistent threat of cyberattacks erodes the trust necessary for stakeholders to fully transition from paper-based workflows to digital systems.

This precarious security landscape is emphasized by recent industry data highlighting the vulnerability of health information systems. According to the 'American Hospital Association' in 2025, the protected health information of 259 million Americans had been reported as hacked by the end of 2024. This alarming statistic illustrates the scale of the security risks that e-prescription platforms must mitigate. The necessity to defend against such widespread vulnerabilities drives up implementation costs and complicates the deployment of seamless global solutions, thereby restricting the market's potential for rapid scalability.

Market Trends

The automation of Electronic Prior Authorization (ePA) workflows is reshaping the market by replacing laborious manual processes with real-time, algorithmic approvals. This trend directly addresses the administrative bottlenecks that delay patient access to medication, advancing beyond simple digitization toward fully "touchless" adjudication. By integrating payer criteria directly into the prescribing workflow, providers can receive instant determinations, significantly reducing the time spent on phone calls and faxes. Surescripts highlighted this efficiency in their March 2025 '2024 Annual Impact Report,' noting that Touchless Prior Authorization capabilities lowered the average approval time from over an hour to merely 34 seconds, demonstrating the profound efficiency gains achievable through advanced automation.

Simultaneously, the integration of Artificial Intelligence for Clinical Decision Support is enhancing the accuracy and speed of prescription generation. AI algorithms are increasingly deployed to interpret unstructured clinical data and automate complex tasks such as translating narrative instructions into structured codes, thereby minimizing human error and manual entry fatigue. This technological evolution allows systems to intelligently predict and populate prescription details, ensuring higher data integrity for pharmacies. As evidenced in a July 2025 press release regarding Hackensack Meridian Health's partnership with DrFirst, the deployment of clinical-grade AI enabled the system to automatically map 86% of sigs (patient instructions) across a sample of 300,000 medications, validating the capability of AI to streamline high-volume prescribing operations.

Key Market Players

  • Cerner Corporation
  • Allscripts Healthcare Solutions, Inc.
  • Epic Systems Corporation
  • McKesson Corporation
  • eClinicalWorks LLC
  • GE Healthcare
  • NextGen Healthcare, Inc.
  • DrFirst, Inc.
  • Greenway Health, LLC
  • Practice Fusion, Inc.

Report Scope

In this report, the Global E-Prescription Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

E-Prescription Market, By Component

  • Solutions {Standalone Solutions & Integrated Solutions}
  • Services

E-Prescription Market, By Mode of Delivery

  • On-Premises Solutions
  • Web/Cloud-based Solutions

E-Prescription Market, By End-User Segment Analysis

  • Hospitals
  • Pharmacies & Clinics

E-Prescription Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global E-Prescription Market.

Available Customizations:

Global E-Prescription Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global E-Prescription Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Solutions {Standalone Solutions & Integrated Solutions} & Services)
    • 5.2.2. By Mode Of Delivery (On-Premises Solutions & Web/Cloud-based Solutions)
    • 5.2.3. By End-User Segment Analysis (Hospitals, Pharmacies & Clinics)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America E-Prescription Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Mode Of Delivery
    • 6.2.3. By End-User Segment Analysis
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States E-Prescription Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Mode Of Delivery
        • 6.3.1.2.3. By End-User Segment Analysis
    • 6.3.2. Canada E-Prescription Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Mode Of Delivery
        • 6.3.2.2.3. By End-User Segment Analysis
    • 6.3.3. Mexico E-Prescription Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Mode Of Delivery
        • 6.3.3.2.3. By End-User Segment Analysis

7. Europe E-Prescription Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Mode Of Delivery
    • 7.2.3. By End-User Segment Analysis
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany E-Prescription Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Mode Of Delivery
        • 7.3.1.2.3. By End-User Segment Analysis
    • 7.3.2. France E-Prescription Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Mode Of Delivery
        • 7.3.2.2.3. By End-User Segment Analysis
    • 7.3.3. United Kingdom E-Prescription Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Mode Of Delivery
        • 7.3.3.2.3. By End-User Segment Analysis
    • 7.3.4. Italy E-Prescription Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Mode Of Delivery
        • 7.3.4.2.3. By End-User Segment Analysis
    • 7.3.5. Spain E-Prescription Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Mode Of Delivery
        • 7.3.5.2.3. By End-User Segment Analysis

8. Asia Pacific E-Prescription Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Mode Of Delivery
    • 8.2.3. By End-User Segment Analysis
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China E-Prescription Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Mode Of Delivery
        • 8.3.1.2.3. By End-User Segment Analysis
    • 8.3.2. India E-Prescription Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Mode Of Delivery
        • 8.3.2.2.3. By End-User Segment Analysis
    • 8.3.3. Japan E-Prescription Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Mode Of Delivery
        • 8.3.3.2.3. By End-User Segment Analysis
    • 8.3.4. South Korea E-Prescription Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Mode Of Delivery
        • 8.3.4.2.3. By End-User Segment Analysis
    • 8.3.5. Australia E-Prescription Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Mode Of Delivery
        • 8.3.5.2.3. By End-User Segment Analysis

9. Middle East & Africa E-Prescription Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Mode Of Delivery
    • 9.2.3. By End-User Segment Analysis
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia E-Prescription Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Mode Of Delivery
        • 9.3.1.2.3. By End-User Segment Analysis
    • 9.3.2. UAE E-Prescription Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Mode Of Delivery
        • 9.3.2.2.3. By End-User Segment Analysis
    • 9.3.3. South Africa E-Prescription Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Mode Of Delivery
        • 9.3.3.2.3. By End-User Segment Analysis

10. South America E-Prescription Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Mode Of Delivery
    • 10.2.3. By End-User Segment Analysis
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil E-Prescription Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Mode Of Delivery
        • 10.3.1.2.3. By End-User Segment Analysis
    • 10.3.2. Colombia E-Prescription Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Mode Of Delivery
        • 10.3.2.2.3. By End-User Segment Analysis
    • 10.3.3. Argentina E-Prescription Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Mode Of Delivery
        • 10.3.3.2.3. By End-User Segment Analysis

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global E-Prescription Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Cerner Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Allscripts Healthcare Solutions, Inc.
  • 15.3. Epic Systems Corporation
  • 15.4. McKesson Corporation
  • 15.5. eClinicalWorks LLC
  • 15.6. GE Healthcare
  • 15.7. NextGen Healthcare, Inc.
  • 15.8. DrFirst, Inc.
  • 15.9. Greenway Health, LLC
  • 15.10. Practice Fusion, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer